FDA Disclaimer

Last Updated: October 14, 2025
Operator: Aqualanes Limited ("Aqualanes", "DERMXELL⁺", "we", "us", or "our")

1. INTRODUCTION AND SCOPE OF APPLICATION

Aqualanes Limited operates the DERMXELL⁺ website, online store, and associated digital marketing channels (the "Services") to provide customers with premium cosmetic and anti-aging products. This FDA Disclaimer and Regulatory Compliance document governs all product claims, safety information, usage guidelines, and regulatory compliance standards for DERMXELL⁺ Age Defying Lift & Firm Cream and all associated cosmetic products distributed by Aqualanes Limited.

This disclaimer has been specifically designed to ensure comprehensive compliance with all major advertising platform policies including AppLovin Corporation, Google LLC (including YouTube), Meta Platforms Inc. (Facebook/Instagram), TikTok, Shopify Inc., and other approved digital advertising networks. By accessing our Services, purchasing our products, or engaging with our advertising content across any platform, you acknowledge that you have read, understood, and accepted all provisions contained herein.

CRITICAL ADVERTISING PLATFORM COMPLIANCE DECLARATION: This FDA Disclaimer document is designed to ensure comprehensive compliance with all major advertising platform health and wellness policies, cosmetic product advertising requirements, and claim substantiation standards effective as of October 2025.

2. MANDATORY FDA DISCLAIMER AND REGULATORY CLASSIFICATION

2.1 PRIMARY FDA DISCLAIMER (REQUIRED BY LAW)

"These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary based on skin type, age, lifestyle, genetic factors, environmental conditions, and adherence to usage instructions."

2.2 COSMETIC PRODUCT CLASSIFICATION

DERMXELL⁺ products are classified as cosmetic preparations under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(i)) and international cosmetic regulations. Our products are NOT:

  • Medical devices requiring FDA clearance or approval
  • Pharmaceuticals requiring prescription or medical supervision
  • Therapeutic goods making disease treatment claims
  • Dietary supplements for internal consumption
  • Over-the-counter drugs with active pharmaceutical ingredients

2.3 REGULATORY JURISDICTION COMPLIANCE

United States: Full compliance with FDA cosmetic regulations (21 CFR Parts 700-740), FTC advertising guidelines, and state-specific cosmetic requirements

International Compliance: Products manufactured and labeled in accordance with:

  • EU Cosmetic Regulation (EC) No 1223/2009 for European distribution
  • Health Canada cosmetic regulations (Cosmetic Regulations SOR/2001-174)
  • UK post-Brexit cosmetic safety requirements (UK Cosmetic Products Regulation)
  • Australian Therapeutic Goods Administration (TGA) cosmetic standards
  • Additional jurisdictional requirements as applicable to distribution territories

3. COMPREHENSIVE ADVERTISING PLATFORM COMPLIANCE FRAMEWORK

3.1 APPLOVIN CORPORATION COMPLIANCE

MANDATORY APPLOVIN HEALTH & WELLNESS COMPLIANCE: All DERMXELL⁺ advertising through AppLovin's network strictly adheres to AppLovin's Health & Wellness advertising policies:

  • No Medical Claims: We make no disease treatment, cure, or medical therapy claims
  • Cosmetic Classification: All claims limited to cosmetic benefits (appearance, cleansing, beautifying)
  • Evidence-Based Claims: All efficacy claims supported by clinical testing and user studies
  • Age-Appropriate Content: No targeting or content directed toward users under 18 years of age
  • Sensitive Data Restrictions: Full compliance with AppLovin's sensitive personal data limitations

APPLOVIN-SPECIFIC PROTECTIONS:

  • No collection or processing of health data for advertising targeting
  • No sensitive personal information used in custom audience creation
  • Proper consent flag transmission for EU/EEA/UK users in compliance with applicable laws
  • Data retention limited to 13 months maximum per AppLovin policies

3.2 GOOGLE LLC AND YOUTUBE COMPLIANCE

GOOGLE HEALTH & BEAUTY ADVERTISING COMPLIANCE: DERMXELL⁺ advertising through Google Ads and YouTube strictly complies with Google's health and beauty product policies:

  • Cosmetic Claims Only: All advertising claims limited to cosmetic benefits and appearance enhancement
  • No Medical Representations: No claims about treating, curing, or preventing medical conditions
  • Age-Appropriate Targeting: No advertising directed toward users under 18 years of age
  • Substantiated Claims: All product claims supported by clinical evidence and proper documentation

YOUTUBE COMMUNITY GUIDELINES COMPLIANCE:

  • All video content meets YouTube's advertiser-friendly content guidelines
  • Full compliance with YouTube's health and wellness content restrictions
  • Enhanced transparency measures effective 2025 including advertiser identity disclosure
  • No targeting of family-friendly content or channels primarily viewed by minors

3.3 META PLATFORMS (FACEBOOK/INSTAGRAM) ENHANCED COMPLIANCE

META HEALTH & WELLNESS DATA RESTRICTIONS (2025): MANDATORY COMPLIANCE DECLARATION: "We strictly comply with Meta's enhanced health and wellness data restrictions effective January 2025. We expressly do not target advertisements based on sensitive health categories, health conditions, fitness data, wellness behaviors, medical history, pharmaceutical interests, or healthcare service utilization."

META-SPECIFIC PROTECTIONS:

  • Complete exclusion of health-related behavioral data from all targeting
  • No custom audiences containing health or wellness behavioral indicators
  • Full compliance with sensitive category restrictions for cosmetic products
  • Enhanced user control mechanisms for health-related advertising preferences
  • Data minimization to anonymized purchase events and explicit consent-verified matching

FACEBOOK/INSTAGRAM ADVERTISING STANDARDS:

  • All creative content complies with Meta Community Standards and Advertising Policies
  • No before/after imagery that implies medical transformation or unrealistic results
  • Clear distinction between cosmetic benefits and medical claims in all advertising copy

3.4 SHOPIFY PLATFORM COMPLIANCE

SHOPIFY MERCHANT COMPLIANCE: All e-commerce operations through Shopify comply with:

  • Shopify's Acceptable Use Policy for health and beauty products
  • Payment Services Agreement and merchant requirements
  • Customer data protection and privacy standards
  • Anti-fraud and compliance system integration

4. PRODUCT SAFETY, CLINICAL TESTING, AND EFFICACY DISCLAIMERS

4.1 CLINICAL TESTING TRANSPARENCY

Clinical Study Disclosure: DERMXELL⁺ efficacy claims are based on:

  • Clinical testing with a substantial number of participants over multiple weeks
  • Dermatologist-monitored study protocols with measurable outcomes
  • Consumer use studies with statistically relevant sample sizes
  • Ingredient safety and compatibility testing under controlled conditions

Study Limitations: Clinical results represent average improvements observed in study participants. Individual results will vary based on factors including but not limited to skin type, age, genetic predisposition, environmental exposure, lifestyle factors, product usage consistency, and adherence to application instructions.

4.2 INDIVIDUAL RESULTS VARIATION DISCLAIMER

CRITICAL USER ACKNOWLEDGMENT: Results from DERMXELL⁺ products may vary significantly among individual users. Factors affecting individual outcomes include:

Biological Factors:

  • Individual skin type (dry, oily, combination, sensitive, mature)
  • Age and hormonal status
  • Genetic predisposition to aging patterns
  • Pre-existing skin conditions or sensitivities
  • Medication use affecting skin condition

Environmental Factors:

  • Climate and environmental exposure (sun, pollution, humidity)
  • Lifestyle factors (sleep, stress, nutrition, hydration)
  • Skincare routine and product compatibility
  • Consistency and frequency of product application

Usage Factors:

  • Adherence to recommended application instructions
  • Proper product storage and handling
  • Integration with existing skincare routines
  • Duration of consistent product use

4.3 SAFETY TESTING AND HYPOALLERGENIC CLAIMS

Dermatologist Testing: DERMXELL⁺ products undergo comprehensive safety testing including:

  • Dermatologist-supervised patch testing for skin compatibility
  • Clinical irritation and sensitization studies
  • Hypoallergenic formulation testing (formulated to minimize allergic reactions)
  • Non-comedogenic testing (formulated to minimize pore clogging)

Safety Considerations: While products are formulated to minimize adverse reactions, individual skin sensitivities may vary. Users with known sensitivities should:

  • Perform patch testing before full application
  • Discontinue use if irritation, redness, or adverse reactions occur
  • Consult dermatological professionals for persistent skin concerns

5. INGREDIENT SAFETY, PEPTIDE COMPLEX DISCLOSURES, AND FORMULATION TRANSPARENCY

5.1 TRIPLE KING PEPTIDE COMPLEX DISCLOSURE

Active Ingredient Transparency: DERMXELL⁺ contains the following clinically-tested peptide complex:

Progeline™: Cosmetic peptide designed to target skin firmness and elasticity (not a medical treatment) Matrixyl 3000®: Cosmetic peptide complex for appearance of skin texture and smoothness Argireline®: Cosmetic peptide for temporary appearance of expression line reduction

Peptide Limitations: Peptide ingredients provide cosmetic benefits related to skin appearance and texture. These ingredients do not:

  • Treat medical conditions or skin diseases
  • Provide pharmaceutical-grade therapeutic effects
  • Replace medical treatments for skin disorders
  • Guarantee permanent or irreversible changes to skin structure

5.2 FORMULATION SAFETY STANDARDS

Clean Beauty Commitment: DERMXELL⁺ products are formulated WITHOUT:

  • Parabens, sulfates, phthalates, or harsh BHA/BHT preservatives
  • Artificial fragrances or synthetic colorants
  • Known pore-clogging heavy oils or comedogenic ingredients
  • Animal-derived ingredients (100% cruelty-free formulation)

Manufacturing Standards: Products manufactured in:

  • ISO-certified facilities following Good Manufacturing Practice (GMP) standards
  • Quality control environments with third-party oversight
  • Third-party tested facilities for purity and potency verification
  • Climate-controlled storage and distribution systems

5.3 PREGNANCY, NURSING, AND SPECIAL POPULATIONS

Special Population Guidance:

  • Pregnant or nursing women should consult healthcare providers before use
  • Individuals with known skin allergies should perform patch testing
  • Users taking medications affecting skin sensitivity should seek medical advice
  • Children under 18 should not use anti-aging cosmetic products

6. ADVERTISING CLAIM SUBSTANTIATION AND TRUTH-IN-ADVERTISING COMPLIANCE

6.1 CLINICAL CLAIM VERIFICATION

Substantiated Claims: All DERMXELL⁺ advertising claims are supported by:

  • Independent third-party clinical testing with documented methodology
  • Internal clinical research studies on product formulation and efficacy
  • Consumer use studies with measurable before/after assessments
  • Dermatologist evaluation and professional endorsement

Prohibited Claims: DERMXELL⁺ advertising does NOT claim to:

  • Treat, cure, or prevent any disease or medical condition
  • Provide pharmaceutical-grade or prescription-strength effects
  • Achieve permanent or irreversible changes to skin structure
  • Replace medical treatments or professional dermatological care

6.2 BEFORE/AFTER IMAGERY AND TESTIMONIAL STANDARDS

Authentic Representation: All before/after imagery and customer testimonials represent:

  • Genuine customer experiences with verified product usage
  • Consistent lighting and photography conditions without excessive digital enhancement
  • Typical results achievable with consistent product use over recommended timeframes
  • Individual experiences that may not be representative of all users

Testimonial Limitations: Customer testimonials and reviews represent individual opinions and experiences. Results described in testimonials:

  • May not be typical or representative of all users
  • Reflect individual skin response and usage patterns
  • Should not be considered as medical advice or professional recommendations
  • Are supplemented by clinical testing data for validation

6.3 NUMERICAL CLAIMS AND STATISTICAL REPRESENTATIONS

Clinical Study Results: Efficacy claims (e.g., "the majority of participants saw visible results") are derived from:

  • Controlled clinical studies with defined participant criteria
  • Specific measurement methodologies and evaluation timeframes
  • Professional dermatologist assessment combined with participant self-evaluation
  • Statistical analysis meeting industry standards for cosmetic research

Statistical Considerations: Numerical claims represent study population trends and may not predict individual user results. Factors affecting individual outcomes include compliance with usage instructions, skin type variations, and environmental considerations.

7. GLOBAL IMPORT/EXPORT COMPLIANCE AND INTERNATIONAL REGULATORY FRAMEWORKS

7.1 INTERNATIONAL DISTRIBUTION COMPLIANCE

Global Regulatory Adherence: DERMXELL⁺ products distributed internationally comply with:

European Union: EU Cosmetic Regulation (EC) No 1223/2009 including:

  • Cosmetic Product Safety Report (CPSR) by qualified safety assessor
  • Product Information File (PIF) with complete technical documentation
  • CPNP (Cosmetic Product Notification Portal) registration
  • Responsible Person designation within the European Union

United Kingdom: UK Cosmetic Products Regulation compliance including:

  • UK-specific safety assessment and documentation
  • Responsible Person appointment in Great Britain
  • Post-Brexit regulatory requirement adherence

Canada: Health Canada cosmetic regulations compliance including:

  • Cosmetic notification and ingredient disclosure requirements
  • Good Manufacturing Practice (GMP) adherence
  • Safety substantiation documentation

Australia: Therapeutic Goods Administration (TGA) compliance including:

  • Australian Consumer Law advertising requirements
  • Cosmetic product safety and labeling standards

7.2 IMPORT DUTY AND CUSTOMS DISCLAIMER

International Customer Responsibilities: Customers ordering DERMXELL⁺ products for international delivery acknowledge and accept:

Import Obligations: All import duties, value-added taxes (VAT), goods and services taxes (GST), customs fees, brokerage charges, and other governmental levies imposed by destination jurisdictions are the exclusive responsibility of the recipient.

Regulatory Compliance: Customers are responsible for ensuring that importation and use of DERMXELL⁺ products complies with all applicable destination country laws, regulations, cosmetic standards, and import requirements.

Customs Documentation: While Aqualanes Limited provides accurate customs documentation, customers may be required to provide additional information, permits, or documentation required by customs authorities to facilitate clearance and delivery.

7.3 RESTRICTED JURISDICTIONS AND TRADE COMPLIANCE

Export Control Compliance: DERMXELL⁺ distribution complies with:

  • U.S. Department of Commerce Export Administration Regulations
  • EU dual-use export control regulations
  • UK Export Control Organisation requirements
  • International trade sanctions and embargo restrictions

Prohibited Destinations: Products may not be available for shipment to certain jurisdictions due to:

  • International trade sanctions or embargos
  • Local import prohibitions or cosmetic regulation incompatibilities
  • Commercial restrictions or elevated risk assessments

8. ENHANCED CONSUMER PROTECTION AND SAFETY GUIDELINES

8.1 PROPER USAGE INSTRUCTIONS AND SAFETY PROTOCOLS

Application Guidelines: For optimal safety and results:

  • Apply to clean, dry skin as directed in product instructions
  • Use only the recommended amount (pearl-sized dollop for face and neck)
  • Perform patch testing on small skin area before full application
  • Discontinue use immediately if irritation, redness, or adverse reactions occur

Storage and Handling: To maintain product integrity and safety:

  • Store in cool, dry place away from direct sunlight and extreme temperatures
  • Keep container tightly closed when not in use
  • Avoid contamination by using clean hands or application tools
  • Check expiration date and discontinue use of expired products

8.2 CONTRAINDICATIONS AND PRECAUTIONARY WARNINGS

Do Not Use If:

  • You have known allergies to any listed ingredients
  • You are currently using prescription retinoids without dermatologist approval
  • You have active skin infections, wounds, or severe skin conditions
  • You are undergoing professional cosmetic treatments without professional guidance

Seek Professional Advice:

  • Before use if pregnant, nursing, or planning pregnancy
  • If you experience persistent skin irritation or unusual reactions
  • Before combining with prescription skincare medications
  • If you have a history of severe allergic reactions to cosmetic products

8.3 EMERGENCY RESPONSE AND ADVERSE REACTION PROTOCOLS

Immediate Response to Adverse Reactions:

  • Discontinue product use immediately
  • Rinse affected area thoroughly with cool water
  • Avoid further exposure to potential allergens
  • Document reaction symptoms and timeline

Professional Medical Attention Required If:

  • Severe skin reaction persists after discontinuation
  • Signs of allergic reaction (difficulty breathing, widespread rash, severe swelling)
  • Infection develops at application site
  • Reaction affects eyes or mucous membranes

Adverse Event Reporting: Customers experiencing adverse reactions should report incidents to:

  • Aqualanes Limited: support@dermxell.com
  • FDA MedWatch Program (for U.S. customers): www.fda.gov/medwatch
  • Health Canada (for Canadian customers): www.canada.ca/en/health-canada/services/consumer-product-safety
  • Relevant national authorities for international customers

9. COMPREHENSIVE LIABILITY LIMITATIONS AND LEGAL PROTECTIONS

9.1 PRODUCT LIABILITY LIMITATIONS

Maximum Liability Cap: Aqualanes Limited's total aggregate liability for any claims arising from DERMXELL⁺ products shall not exceed the total amount paid by the customer for the specific product giving rise to the claim.

Excluded Damages: To the fullest extent permitted by applicable law, Aqualanes Limited shall not be liable for:

  • Indirect, incidental, special, exemplary, or consequential damages
  • Loss of profits, business interruption, or loss of business opportunities
  • Punitive or exemplary damages regardless of the legal theory of recovery
  • Damages arising from misuse, modification, or failure to follow instructions

9.2 COSMETIC PRODUCT SPECIFIC LIMITATIONS

Warranty Considerations: Aqualanes Limited provides limited warranties regarding:

  • Product satisfaction guarantee for a specified period
  • Replacement of manufacturing defects within warranty period
  • Refund eligibility as outlined in our Return and Refund Policy

9.3 FORCE MAJEURE AND BUSINESS INTERRUPTION PROTECTIONS

Force Majeure Events: Aqualanes Limited is not liable for delays or failures caused by circumstances beyond reasonable control, including:

  • Regulatory changes affecting cosmetic product distribution
  • Supply chain disruptions or raw material shortages
  • Manufacturing facility closures or capacity limitations
  • International trade restrictions or customs delays

10. THIRD-PARTY VERIFICATION AND PROFESSIONAL ENDORSEMENTS

10.1 DERMATOLOGIST INVOLVEMENT AND PROFESSIONAL OVERSIGHT

Professional Development: DERMXELL⁺ formulation developed with:

  • Licensed dermatologist consultation and oversight
  • Clinical research scientist involvement in ingredient selection
  • Independent safety assessor evaluation and approval
  • Ongoing professional monitoring of product performance

Professional Endorsement Limitations: Any dermatologist or professional endorsements:

  • Represent individual professional opinions based on available data
  • Do not constitute medical advice or treatment recommendations
  • Should be considered alongside individual skin assessment by personal healthcare providers
  • May not be representative of all professional opinions in the field

10.2 THIRD-PARTY TESTING AND CERTIFICATION

Independent Verification: Product safety and efficacy verified through:

  • Third-party laboratory testing for ingredient purity and potency
  • Independent clinical research organizations conducting efficacy studies
  • Certified testing facilities for safety and compatibility assessments
  • Quality assurance programs meeting international cosmetic standards

Certification Limitations: Third-party certifications and testing:

  • Reflect testing conditions and methodologies specific to certification requirements
  • May not predict individual user experiences or outcomes
  • Are valid only for tested product formulations and manufacturing batches
  • Should be considered as part of overall product evaluation, not exclusive determining factors

11. DIGITAL MARKETING COMPLIANCE AND PLATFORM-SPECIFIC REQUIREMENTS

11.1 SOCIAL MEDIA ADVERTISING COMPLIANCE

Platform Content Standards: All DERMXELL⁺ social media advertising complies with:

  • Platform-specific community guidelines and advertising policies
  • Truth-in-advertising standards for cosmetic product promotion
  • Age-appropriate content and targeting restrictions
  • User privacy and data protection requirements

Influencer and Affiliate Marketing: Sponsored content and affiliate partnerships:

  • Include clear disclosure of commercial relationships (#ad, #sponsored, #partnership)
  • Comply with FTC guidelines for endorsements and testimonials
  • Maintain authentic representation of product experiences
  • Avoid medical claims or therapeutic representations

11.2 EMAIL MARKETING AND CUSTOMER COMMUNICATION

CAN-SPAM Compliance: All email marketing communications:

  • Include clear sender identification and contact information
  • Provide easy unsubscribe mechanisms and honor opt-out requests
  • Avoid deceptive subject lines or misleading promotional content
  • Maintain accurate customer consent records and preferences

Customer Communication Standards: All customer communications:

  • Provide accurate product information and usage guidelines
  • Include appropriate disclaimers and safety information
  • Respect customer privacy and data protection preferences
  • Maintain professional and ethical communication standards

12. CONTINUOUS COMPLIANCE MONITORING AND UPDATES

12.1 Regulatory Monitoring Framework

Ongoing Compliance Assessment: Aqualanes Limited maintains:

  • Regular monitoring of FDA and international regulatory updates
  • Quarterly review of advertising platform policy changes
  • Annual legal compliance audit and documentation review
  • Continuous assessment of industry best practices and standards

Update Implementation: Changes to regulations or platform policies result in:

  • Immediate assessment of compliance requirements
  • Legal team review and recommended implementation strategies
  • Timely updates to product information and marketing materials
  • Customer notification of material changes affecting product use

12.2 Quality Assurance and Improvement Programs

Continuous Improvement: Based on customer feedback and regulatory developments:

  • Regular product formulation review and enhancement
  • Safety monitoring and adverse event tracking
  • Customer satisfaction assessment and product improvement
  • Professional consultation and expert advisory involvement

13. CUSTOMER RIGHTS AND COMPLAINT RESOLUTION

13.1 Customer Service and Support

Comprehensive Support: Customers have access to:

  • Qualified customer service representatives for product questions
  • Dermatologist-developed usage guidelines and safety information
  • Prompt response to product concerns and adverse reaction reports
  • Clear return and refund processes for customer satisfaction

Response Timeline Commitments:

  • General product inquiries: Response within 48 hours
  • Safety concerns: Immediate escalation and response within 24 hours
  • Adverse reaction reports: Priority processing with 24-hour follow-up
  • Return and refund requests: Processing within 5 business days

13.2 Quality Complaint Resolution

Complaint Processing: All product quality complaints receive:

  • Immediate investigation and documentation
  • Product batch tracking and quality assurance review
  • Customer notification of investigation results and resolution
  • Implementation of corrective measures when appropriate

Escalation Procedures: Unresolved complaints may be escalated to:

  • Senior management review and intervention
  • Independent third-party mediation services
  • Relevant regulatory authorities for safety concerns
  • Legal dispute resolution as outlined in Terms of Service

14. CONTACT INFORMATION AND REGULATORY REPORTING

14.1 Primary Contact Information

Aqualanes Limited Regulatory Compliance Office: Email: support@dermxell.com
Subject Line for Regulatory/Safety Concerns: "FDA/Safety Concern" Emergency Safety Contact: support@dermxell.com
Phone: +852 6516 5836

Postal Address: Aqualanes Limited
Regulatory Compliance Officer
Flat/Rm C1207 12/F, Hang Cheong Factory Building
1 Wing Ming Street, Cheung Sha Wan, Kowloon
Hong Kong

14.2 Regulatory Authority Resources

United States:

  • FDA Consumer Complaints: www.fda.gov/safety/report-problem-fda
  • FTC Consumer Sentinel: reportfraud.ftc.gov
  • Better Business Bureau: www.bbb.org

International Authorities:

  • Health Canada: www.canada.ca/en/health-canada/services/consumer-product-safety
  • European Commission (CPNP): ec.europa.eu/growth/tools-databases/cpnp
  • UK Department for Business: www.gov.uk/guidance/cosmetic-products

15. EFFECTIVE DATE AND LEGAL VALIDITY

This FDA Disclaimer and Regulatory Compliance document becomes effective immediately upon publication and supersedes all previous versions. This document constitutes a legally binding agreement between Aqualanes Limited and all users of DERMXELL⁺ products and services.

Legal Enforceability: Should any provision of this FDA Disclaimer be deemed invalid, illegal, or unenforceable by a court of competent jurisdiction, such provision shall be severed, and the remainder of the document shall remain in full force and effect.

Translation Disclaimer: In the event of conflicts between translated versions of this FDA Disclaimer, the English language version shall control and supersede all other versions.

Complete Regulatory Framework: This FDA Disclaimer, together with our Privacy Policy, Terms of Service, Ingredient Safety Guidelines, Data Privacy Rights, and Cookie Policy, constitutes the complete regulatory and legal framework governing DERMXELL⁺ products and services.

Document Authentication:
Document Version: October 14, 2025, 001
Legal Review Date: October 14, 2025
Next Scheduled Review: January 15, 2026
Regulatory Compliance Status: Current as of October 14, 2025
Platform Policy Alignment: Designed to comply with AppLovin, Google, Meta, YouTube, and Shopify advertising policies

This FDA Disclaimer has been prepared to meet the highest standards of regulatory compliance, advertising platform policy adherence, and international legal protection. For specific regulatory questions or compliance interpretations, consult with qualified legal counsel familiar with cosmetic product regulations and international commerce law.